Auriga Laboratories, Inc. (ARGA.OB) Announces Co-Promotion Agreement with MiddleBrook Pharmaceuticals, Inc.
Auriga Laboratories, Inc. (OTCBB: ARGA), has announced the signing of a co-promotion agreement with MiddleBrook Pharmaceuticals, Inc., in which Auriga will co-promote Keflex ® 750mg capsules (cephalexin capsules, USP) to Primary Care Specialists in the U.S. As the third most prescribed outpatient antibiotic in the U.S., Cephalexin (the generic form of Keflex) has approximately 25 million prescriptions written annually. It's also the most prescribed oral cephalosporin antibiotic and the leading oral antibiotic therapy for uncomplicated skin and skin structure infections. The co-promotion is planned to be commenced the first Quarter of 2008. Commenting on the agreement was Philip S. Pesin,…